Biomarker-Guided Nicotine Dosing for Craving-Responsive NRT

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Nicotine addiction makes it difficult for smokers and tobacco users to quit despite negative health consequences, as they struggle with withdrawal symptoms and cravings.

Innovation Solution

A smart nicotine replacement therapy (NRT) device that includes sensors for detecting nicotine use, cravings, and physiological parameters, along with a processor to manage a cessation program, providing personalized guidance and dosage recommendations to manage cravings and withdrawal.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a lockout mechanism is implemented to control nicotine dispensing, then nicotine consumption can be regulated, but user convenience is reduced

Engineering Contradiction:
Improvenicotine consumption regulationVSAvoiduser convenience
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The lockout mechanism uses biometric sensor feedback (heart rate, skin conductance, temperature) to automatically determine when nicotine dispensing should be locked or unlocked. The system continuously monitors physiological parameters and adjusts the lockout state based on real-time craving detection, eliminating the need for manual user intervention while maintaining convenience.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The device performs self-regulation of nicotine dispensing through automated craving detection algorithms. The system independently monitors biometric data, determines craving states, and controls the lockout mechanism without requiring user input, allowing the device to serve itself in managing nicotine consumption patterns.

Inventive Principle:
Principle #25Self-service

2Adaptability or versatility

If biometric sensors are integrated for real-time craving detection, then personalized nicotine dosing is improved, but device complexity increases

Engineering Contradiction:
Improvepersonalized nicotine dosingVSAvoiddevice complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

Multiple biometric sensing functions (heart rate monitoring, skin conductance measurement, temperature sensing) are merged into a single integrated sensor module. This consolidation reduces the overall device complexity while maintaining the capability to detect multiple physiological parameters for comprehensive craving assessment and personalized dosing.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The biometric sensor system is designed to perform multiple functions: detecting nicotine cravings, monitoring withdrawal symptoms, and providing baseline physiological data. This multi-functionality allows a single sensor subsystem to support various aspects of personalized nicotine replacement therapy without proportionally increasing device complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Measurement precision

If continuous biometric monitoring is performed, then craving detection accuracy is improved, but energy consumption increases

Engineering Contradiction:
Improvecraving detection accuracyVSAvoidenergy consumption
Core Design Contradiction:
Measurement precisionVSUse of energy by moving object

Solution Approach 1:

Instead of continuous monitoring, the biometric sensors operate periodically at strategically determined intervals. The system monitors physiological parameters at regular intervals and adjusts monitoring frequency based on detected patterns, maintaining high craving detection accuracy while significantly reducing average power consumption compared to continuous operation.

Inventive Principle:
Principle #19Periodic action

Solution Approach 2:

The device performs preliminary biometric assessments at scheduled intervals to detect early signs of cravings before they peak. By conducting periodic preliminary monitoring, the system maintains high detection accuracy for intervention while consuming less energy than continuous real-time monitoring would require.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS20210338948A1Biomarker Based Nicotine Replacement Therapy
Publication Date: 2021.11.04 MCNEIL AB
  • US20210338948A1 patent drawing
  • US20210338948A1 patent drawing
  • US20210338948A1 patent drawing

AI summary

A device for providing nicotine replacement therapy may be provided. The device may comprise a processor. The processor may be configured to perform one or more actions. A cessation program for a user may be determined. A program intervention event based on a phase of the cessation program may be determined. A marker associated with the user may be determined. A modification to the cessation program may be determined based on the program intervention event.